City Therapeutics, Inc.: director Barry E Greene received 22,649 shares

What happened

• Barry E Greene, a director, received a derivative award covering 22,649 shares on Oct 15, 2026. The filing lists an acquisition price of $0.00 per share, total value $0.00.

Key details

• Transaction date and type: Oct 15, 2026; Grant, award or other acquisition (A).
• Transaction price and value: $0.00 per share; total $0.00.
• Shares owned following the reported transaction: not stated in the filing.
• Footnote F1: Shares underlying this option vest in full upon the earlier of (i) Oct 15, 2027 or (ii) the date of the issuer's next annual meeting of stockholders, subject to the reporting person's continued service on such vesting date.
• Filing timeliness: not indicated in the filing.

Why it may matter

• This filing reports a derivative award (an option grant) rather than an open-market purchase or sale.
• A filing does not show why the insider traded or why the company acted.